Cite
HARVARD Citation
Faheem, . et al. (2021). 1, 2, 3, 4-Tetrahydroisoquinoline (THIQ) as privileged scaffold for anticancer de novo drug design. Expert opinion on drug discovery. pp. 1119-1147. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Faheem, . et al. (2021). 1, 2, 3, 4-Tetrahydroisoquinoline (THIQ) as privileged scaffold for anticancer de novo drug design. Expert opinion on drug discovery. pp. 1119-1147. [Online].